Results for "consumer data right"
371-380 of 776 results for 'consumer data right'
An overhaul of regulation of software as a medical device - what's on the horizon?
Proposed new regulatory rules for software as a medical device will if enacted have serious implications for suppliers to the Australian market who will likely have to meet more stringent requirements that could conflict with those in the US and Europe Special Counsel Ric Morgan and Senior Associate ...
Why every company should have a structured cyber simulation program
The single most determinative factor in how an organisation emerges from a cyberattack is how it conducts itself during the crisis. And the biggest determinant of how an organisation conducts itself during a crisis is how prepared it is. Here are five tips to keep in mind. ...
Disclosure of climate-related financial risk: major change is imminent
There has been a global proliferation of voluntary reporting standards that companies might adopt with respect to disclosure of climate change-related financial risk. ...
KODAKOne: the Kodak Moment moves up the Blockchain
Kodak, in partnership with WENN Digital, recently announced the launch of the KODAKOne digital rights management platform and KODAKCoin cryptocurrency. The goal of the blockchain-based platform is to assist photographers to protect their copyright, license their images and flush out potential infrin ...
ASIC and APRA announce strategic priorities
In this Insight, we consider the key trends, similarities and differences we have observed across ASIC and APRA's Corporate Plan. We also explain what to expect on the regulators' supervision and enforcement agendas in the near future. ...
TGA guidance on the promotion of stem cells and HCT products
The Therapeutic Goods Administration has issued advertising guidance for businesses involved with stems cells and other human cell or tissue products. ...
Imitation is not always the sincerest form of flattery
In this issue we examine a patentees ability to enforce Swiss-style claims against makers of bioequivalent products following the Mylan Health decision ...
ACCC delivers bitter pill on patent settlement
The ACCC proposes to deny authorisation for a patent litigation settlement between Celgene and two generic drug companies. The decision demonstrates a hardening of the ACCC’s views against patent settlements that seek to place restrictions on market participants. ...
Critical minerals outlook: M&A to ramp up in 2025
2024 was a turbulent year for dealmakers, project developers and investors in critical minerals. Immature markets and declining prices driven by the ramp-up of new supply outpacing demand growth impacted both financing availability and dealmaking activity. ...
Australia and Indonesia sign bilateral free trade agreement - what it means for you
After eight years of negotiation, Australia and Indonesia have signed a bilateral free trade agreement that both reduces tariff and non-tariff barriers for trade and investment, and simplifies various regulatory requirements. ...